TherapeuticsMD (TXMD) Total Debt (2010 - 2022)
TherapeuticsMD's (TXMD) quarterly Total Debt came in at $93.6 million in Q3 2022, down 49.88% YoY from $186.7 million in Q3 2021, and up 3.11% on a QoQ basis from $90.8 million in Q2 2022.
TherapeuticsMD (TXMD) Total Debt (2010 - 2022) Analysis & Trends
TherapeuticsMD (TXMD) has 9 years of Total Debt data on file, last reported at $93.6 million in Q3 2022.
- Quarterly Total Debt fell 49.88% year-over-year to $93.6 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $93.6 million (down 49.88% YoY) and the FY2021 annual result came in at $188.3 million, down 20.79% from the prior year.
- Total Debt improved to $93.6 million in Q3 2022, from $90.8 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $243.8 million in Q2 2020 to a low of $73.1 million in Q2 2018.
- A 5-year average of $165.3 million and a median of $188.6 million in 2021 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2020 — Total Debt jumped 231.19% — and 2022, when it plunged 51.0%.
- Tracing TXMD's Total Debt over 5 years: stood at $73.4 million in 2018, then soared by 165.24% to $194.6 million in 2019, then grew by 22.13% to $237.7 million in 2020, then declined by 20.79% to $188.3 million in 2021, then tumbled by 50.28% to $93.6 million in 2022.
- The last three Total Debt figures came in at $93.6 million (Q3 2022), $90.8 million (Q2 2022), and $202.9 million (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.27 Bn | 43.31 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 43.51 Bn | 39.86 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 32.62 Bn | 30.94 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.34 Bn | 19.68 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.87 Bn | 17.99 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 760.00 Mn |
| 10 | TherapeuticsMD | 23.96 Mn | 14.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 93.60 Mn |
| Jun 30, 2022 | 90.78 Mn |
| Mar 31, 2022 | 202.86 Mn |
| Dec 31, 2021 | 188.27 Mn |
| Sep 30, 2021 | 186.74 Mn |
| Jun 30, 2021 | 185.26 Mn |
| Mar 31, 2021 | 188.97 Mn |
| Dec 31, 2020 | 237.70 Mn |
| Sep 30, 2020 | 237.05 Mn |
| Jun 30, 2020 | 243.80 Mn |
| Mar 31, 2020 | 243.43 Mn |
| Dec 31, 2019 | 194.63 Mn |
| Sep 30, 2019 | 194.36 Mn |
| Jun 30, 2019 | 194.10 Mn |
| Mar 31, 2019 | 73.50 Mn |
| Dec 31, 2018 | 73.38 Mn |
| Sep 30, 2018 | 73.26 Mn |
| Jun 30, 2018 | 73.14 Mn |
| Mar 31, 2013 | 100,000.00 |
| Dec 31, 2012 | 3.59 Mn |